QUINAPRIL

QUINAPRIL was reported 7855 times

QUINAPRIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 5-HYDROXYINDOLACETIC ACID IN URINE INCREASED 19 0.3455
1 BLOOD MERCURY ABNORMAL 32 0.3265
2 HEART SOUNDS 31 0.3229
3 5-HYDROXYINDOLACETIC ACID INCREASED 13 0.2000
4 PROLONGED EXPIRATION 32 0.1221
5 SEDATION COMPLICATION 174 0.0681
6 MULTIPLE DRUG THERAPY 41 0.0544
7 RENAL PHOSPHOLIPIDOSIS 7 0.0515
8 FIBROUS HISTIOCYTOMA 17 0.0484
9 BRONCHOMALACIA 6 0.0455
10 CREATININE RENAL CLEARANCE INCREASED 34 0.0455
11 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 17 0.0435
12 EPIDURAL HAEMORRHAGE 5 0.0385
13 CREATININE RENAL CLEARANCE DECREASED 149 0.0372
14 PSEUDOHYPONATRAEMIA 5 0.0365
15 LOW DENSITY LIPOPROTEIN DECREASED 32 0.0226
16 RECALLED PRODUCT ADMINISTERED 203 0.0213
17 MERYCISM 6 0.0210
18 COGWHEEL RIGIDITY 16 0.0152
19 BLOOD CALCIUM DECREASED 157 0.0139
20 HEAD TITUBATION 16 0.0116
21 SPINAL CORD INFARCTION 5 0.0113
22 ORTHOSTATIC HYPOTENSION 189 0.0108
23 HEPATIC NEOPLASM 35 0.0107
24 RENAL FUNCTION TEST ABNORMAL 43 0.0093
25 GINGIVAL DISCOMFORT 6 0.0091
26 DEPRESSIVE SYMPTOM 32 0.0091
27 INTENTION TREMOR 5 0.0088
28 UPPER AIRWAY OBSTRUCTION 7 0.0079
29 ANTICHOLINERGIC SYNDROME 12 0.0075
30 HYPERPARATHYROIDISM SECONDARY 18 0.0072
31 CALCULUS URETERIC 5 0.0069
32 NEPHROGENIC ANAEMIA 32 0.0069
33 AORTIC CALCIFICATION 4 0.0069
34 AORTIC VALVE SCLEROSIS 5 0.0068
35 SEDATION 177 0.0068
36 RALES 38 0.0065
37 ARTERIOSCLEROSIS CORONARY ARTERY 41 0.0062
38 INTERMITTENT CLAUDICATION 9 0.0057
39 REBOUND ACID HYPERSECRETION 17 0.0056
40 CARDIOPULMONARY FAILURE 20 0.0051
41 AORTIC DISORDER 4 0.0051
42 RESPIRATION ABNORMAL 34 0.0049
43 PRODUCT COATING ISSUE 5 0.0049
44 METABOLIC SYNDROME 8 0.0049
45 APPETITE DISORDER 32 0.0048
46 CAROTID ARTERY DISEASE 6 0.0047
47 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 5 0.0047
48 HAEMORRHAGIC ANAEMIA 20 0.0045
49 CERUMEN IMPACTION 4 0.0044
50 ESSENTIAL HYPERTENSION 8 0.0044
51 COGNITIVE DISORDER 195 0.0042
52 FLANK PAIN 38 0.0040
53 DEPRESSED LEVEL OF CONSCIOUSNESS 159 0.0040
54 CAROTID ARTERY STENOSIS 14 0.0040
55 LEFT ATRIAL DILATATION 5 0.0039
56 BLOOD PRESSURE INADEQUATELY CONTROLLED 23 0.0038
57 RHONCHI 5 0.0036
58 SPONDYLOLISTHESIS 6 0.0035
59 BLADDER DISORDER 34 0.0034
60 END STAGE RENAL DISEASE 61 0.0033
61 JOINT DESTRUCTION 5 0.0032
62 INFREQUENT BOWEL MOVEMENTS 8 0.0032
63 BLOOD PRESSURE DIASTOLIC DECREASED 23 0.0031
64 RADICULOPATHY 8 0.0030
65 CORONARY ARTERIAL STENT INSERTION 15 0.0030
66 BREAST DISORDER 6 0.0029
67 URINE FLOW DECREASED 7 0.0029
68 GUILLAIN-BARRE SYNDROME 14 0.0029
69 NEOPLASM 33 0.0029
70 CARDIOVERSION 4 0.0029
71 DILATATION VENTRICULAR 6 0.0029
72 HAEMATOCRIT DECREASED 55 0.0028
73 BLOOD PRESSURE SYSTOLIC INCREASED 52 0.0027
74 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 11 0.0026
75 AORTIC STENOSIS 9 0.0026
76 ELECTROCARDIOGRAM T WAVE ABNORMAL 4 0.0026
77 BALANCE DISORDER 221 0.0026
78 ORTHOPNOEA 8 0.0025
79 AORTIC VALVE DISEASE 4 0.0025
80 SELF ESTEEM DECREASED 6 0.0025
81 MOBILITY DECREASED 176 0.0024
82 SUBILEUS 5 0.0024
83 WALKING DISABILITY 5 0.0024
84 NEPHROPATHY 22 0.0024
85 HEPATOSPLENOMEGALY 6 0.0023
86 AORTIC ARTERIOSCLEROSIS 6 0.0023
87 LOSS OF EMPLOYMENT 7 0.0023
88 SUPRAVENTRICULAR TACHYCARDIA 22 0.0023
89 ISCHAEMIC CARDIOMYOPATHY 7 0.0023
90 LIMB MASS 5 0.0023
91 DIABETIC NEUROPATHY 11 0.0022
92 GLYCOSYLATED HAEMOGLOBIN INCREASED 56 0.0022
93 CHRONIC KIDNEY DISEASE 168 0.0022
94 REACTION TO EXCIPIENT 5 0.0022
95 DYSLIPIDAEMIA 11 0.0022
96 HIGH DENSITY LIPOPROTEIN DECREASED 7 0.0021
97 BILIARY COLIC 6 0.0021
98 URINE ODOUR ABNORMAL 12 0.0020
99 ELECTROCARDIOGRAM ABNORMAL 16 0.0020
100 ARTERIOSCLEROSIS 19 0.0020
101 AZOTAEMIA 8 0.0020
102 METABOLIC ENCEPHALOPATHY 6 0.0020
103 ANGINA PECTORIS 57 0.0020
104 ECONOMIC PROBLEM 30 0.0020
105 BLOOD PRESSURE DIASTOLIC ABNORMAL 5 0.0020
106 RENAL FAILURE CHRONIC 15 0.0019
107 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 33 0.0019
108 HYPOTONIA 19 0.0019
109 HYPOVOLAEMIA 11 0.0019
110 ANGIONEUROTIC OEDEMA 5 0.0019
111 VENTRICULAR HYPOKINESIA 6 0.0019
112 BLOOD TESTOSTERONE INCREASED 4 0.0019
113 LOSS OF CONTROL OF LEGS 7 0.0018
114 RENAL TUBULAR NECROSIS 18 0.0018
115 CLONUS 5 0.0018
116 SPINAL OSTEOARTHRITIS 16 0.0018
117 DIABETIC NEPHROPATHY 4 0.0018
118 RESPIRATORY RATE INCREASED 16 0.0018
119 THERAPEUTIC AGENT TOXICITY 6 0.0018
120 LEFT VENTRICULAR DYSFUNCTION 12 0.0018
121 BLOOD PRESSURE FLUCTUATION 43 0.0018
122 CORONARY ARTERY STENOSIS 9 0.0018
123 PROSTATOMEGALY 7 0.0018
124 MITRAL VALVE INCOMPETENCE 20 0.0018
125 CARDIAC VALVE DISEASE 10 0.0017
126 PSYCHOLOGICAL TRAUMA 15 0.0017
127 PERIORBITAL OEDEMA 9 0.0017
128 HYPERTONIC BLADDER 5 0.0017
129 PEMPHIGOID 13 0.0017
130 DEMENTIA 48 0.0017
131 ANGINA UNSTABLE 11 0.0017
132 ATYPICAL PNEUMONIA 5 0.0017
133 GAMMA-GLUTAMYLTRANSFERASE INCREASED 37 0.0017
134 HYPERCAPNIA 5 0.0017
135 CEREBROVASCULAR DISORDER 5 0.0017
136 BUNDLE BRANCH BLOCK LEFT 7 0.0016
137 DYSPNOEA EXERTIONAL 62 0.0016
138 HAEMORRHOIDAL HAEMORRHAGE 8 0.0016
139 TRICUSPID VALVE INCOMPETENCE 13 0.0016
140 BLOOD PRESSURE SYSTOLIC ABNORMAL 4 0.0016
141 LYMPHOEDEMA 11 0.0016
142 BREAST CANCER RECURRENT 5 0.0016
143 AUTOIMMUNE HEPATITIS 11 0.0016
144 RENAL FAILURE ACUTE 67 0.0016
145 TROPONIN INCREASED 12 0.0016
146 RED BLOOD CELL COUNT DECREASED 45 0.0016
147 MYOCARDITIS 18 0.0016
148 BLOOD POTASSIUM DECREASED 47 0.0016
149 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 8 0.0016
150 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0015
151 BLOOD PRESSURE DIASTOLIC INCREASED 7 0.0015
152 ATRIAL FLUTTER 12 0.0015
153 CARDIAC MURMUR 13 0.0015
154 BLOOD SODIUM INCREASED 4 0.0015
155 HYPOTENSION 297 0.0015
156 B-CELL LYMPHOMA 5 0.0015
157 SUDDEN CARDIAC DEATH 5 0.0015
158 BLOOD PHOSPHORUS INCREASED 4 0.0015
159 BRONCHOPNEUMONIA 5 0.0015
160 CORONARY ARTERY OCCLUSION 20 0.0015
161 GASTRIC ULCER HAEMORRHAGE 8 0.0014
162 CONGESTIVE CARDIOMYOPATHY 6 0.0014
163 PULSELESS ELECTRICAL ACTIVITY 6 0.0014
164 MULTIPLE INJURIES 9 0.0014
165 ANGIOEDEMA 63 0.0014
166 HYPERLIPIDAEMIA 17 0.0014
167 LIP OEDEMA 6 0.0014
168 RENAL INJURY 42 0.0014
169 AORTIC VALVE INCOMPETENCE 6 0.0014
170 LUNG NEOPLASM 6 0.0014
171 PRODUCTIVE COUGH 67 0.0014
172 LEFT VENTRICULAR HYPERTROPHY 6 0.0014
173 ATRIOVENTRICULAR BLOCK FIRST DEGREE 6 0.0014
174 LEUKOCYTOSIS 25 0.0014
175 HAIR COLOUR CHANGES 17 0.0014
176 EXPIRED PRODUCT ADMINISTERED 45 0.0014
177 ATELECTASIS 13 0.0013
178 CARDIOTOXICITY 12 0.0013
179 ATRIOVENTRICULAR BLOCK COMPLETE 9 0.0013
180 RETINOPATHY 5 0.0013
181 HEART RATE DECREASED 47 0.0013
182 HAIR DISORDER 11 0.0013
183 CARDIAC FAILURE CONGESTIVE 107 0.0013
184 PARALYSIS 19 0.0013
185 CONSTIPATION 289 0.0013
186 ACUTE MYOCARDIAL INFARCTION 39 0.0013
187 ATRIOVENTRICULAR BLOCK SECOND DEGREE 4 0.0013
188 GASTROINTESTINAL MOTILITY DISORDER 7 0.0013
189 DUODENITIS 4 0.0013
190 FALL 430 0.0013
191 CORONARY ARTERY DISEASE 39 0.0013
192 FEELING OF DESPAIR 6 0.0013
193 CHROMATURIA 29 0.0013
194 MUSCLE RUPTURE 5 0.0013
195 HAEMORRHAGIC STROKE 10 0.0013
196 ARTERIAL OCCLUSIVE DISEASE 10 0.0013
197 THERMAL BURN 9 0.0013
198 PULSE ABSENT 6 0.0013
199 BLADDER PAIN 4 0.0013
200 FAECAL INCONTINENCE 6 0.0012
201 RHABDOMYOLYSIS 52 0.0012
202 APHAGIA 6 0.0012
203 CARDIAC FLUTTER 8 0.0012
204 LOWER GASTROINTESTINAL HAEMORRHAGE 9 0.0012
205 CORONARY ARTERY BYPASS 7 0.0012
206 UPPER-AIRWAY COUGH SYNDROME 10 0.0012
207 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 4 0.0012
208 DECREASED ACTIVITY 13 0.0012
209 THYROID FUNCTION TEST ABNORMAL 5 0.0012
210 HAIR TEXTURE ABNORMAL 16 0.0012
211 JOINT RANGE OF MOTION DECREASED 16 0.0012
212 BRONCHIECTASIS 8 0.0012
213 PRODUCT SUBSTITUTION ISSUE 68 0.0012
214 CARDIAC FAILURE CHRONIC 5 0.0012
215 HYPERKALAEMIA 41 0.0012
216 INTERNATIONAL NORMALISED RATIO INCREASED 33 0.0012
217 VENTRICULAR EXTRASYSTOLES 12 0.0012
218 SWOLLEN TONGUE 36 0.0012
219 TONGUE DISCOLOURATION 5 0.0011
220 EMBOLIC STROKE 4 0.0011
221 GRIP STRENGTH DECREASED 10 0.0011
222 NO ADVERSE EVENT 205 0.0011
223 UPPER GASTROINTESTINAL HAEMORRHAGE 19 0.0011
224 VITAMIN D DEFICIENCY 11 0.0011
225 TOXICITY TO VARIOUS AGENTS 190 0.0011
226 UPPER RESPIRATORY TRACT INFECTION 52 0.0011
227 WHEELCHAIR USER 5 0.0011
228 TUBULOINTERSTITIAL NEPHRITIS 21 0.0011
229 NASAL DRYNESS 7 0.0011
230 GASTROINTESTINAL HAEMORRHAGE 93 0.0011
231 STRESS FRACTURE 6 0.0011
232 ACUTE KIDNEY INJURY 170 0.0011
233 BLOOD PRESSURE INCREASED 169 0.0011
234 LOWER RESPIRATORY TRACT INFECTION 50 0.0011
235 BLOOD PRESSURE SYSTOLIC DECREASED 5 0.0011
236 CAROTID ARTERY OCCLUSION 4 0.0011
237 MAJOR DEPRESSION 8 0.0011
238 EJECTION FRACTION DECREASED 17 0.0011
239 ROTATOR CUFF SYNDROME 14 0.0011
240 BUNDLE BRANCH BLOCK RIGHT 5 0.0011
241 PROSTATIC SPECIFIC ANTIGEN INCREASED 15 0.0011
242 CHOKING SENSATION 6 0.0011
243 WHEEZING 64 0.0011
244 RENAL FAILURE 142 0.0011
245 INJURY 75 0.0011
246 HEART RATE IRREGULAR 24 0.0011
247 WALKING AID USER 7 0.0011
248 GOUT 19 0.0011
249 CHOLECYSTITIS ACUTE 6 0.0011
250 SPINAL COLUMN STENOSIS 5 0.0011
251 CARDIOMEGALY 13 0.0011
252 MYOCARDIAL ISCHAEMIA 12 0.0011
253 TENDON RUPTURE 13 0.0011
254 INTERNAL HAEMORRHAGE 12 0.0010
255 VISUAL DISTURBANCE 6 0.0010
256 BLOOD GLUCOSE DECREASED 50 0.0010
257 SEROTONIN SYNDROME 20 0.0010
258 CATARACT 62 0.0010
259 PHARMACEUTICAL PRODUCT COMPLAINT 27 0.0010
260 NASAL CONGESTION 61 0.0010
261 BLOOD GLUCOSE INCREASED 195 0.0010
262 RASH VESICULAR 5 0.0010
263 CONCUSSION 8 0.0010
264 LOCAL SWELLING 18 0.0010
265 BLOOD CALCIUM INCREASED 9 0.0010
266 FLUSHING 104 0.0010
267 JOINT EFFUSION 7 0.0010
268 CARDIOMYOPATHY 15 0.0010
269 HEPARIN-INDUCED THROMBOCYTOPENIA 5 0.0010
270 BREATH SOUNDS ABNORMAL 5 0.0010
271 ARRHYTHMIA 48 0.0010
272 HAIR GROWTH ABNORMAL 7 0.0010
273 LARGE INTESTINE POLYP 7 0.0010
274 TYPE 2 DIABETES MELLITUS 34 0.0010
275 BLOOD SODIUM DECREASED 19 0.0010
276 EXTRAPYRAMIDAL DISORDER 25 0.0010
277 SCIATICA 16 0.0010
278 PROTHROMBIN TIME PROLONGED 6 0.0010
279 EXTRASYSTOLES 7 0.0010
280 INJECTION SITE NODULE 11 0.0010
281 BLEPHARITIS 4 0.0010
282 RED BLOOD CELL SEDIMENTATION RATE INCREASED 11 0.0010
283 SENSORY LOSS 8 0.0010
284 BLOOD COUNT ABNORMAL 15 0.0010
285 BLOOD POTASSIUM INCREASED 16 0.0010
286 TOE AMPUTATION 5 0.0010
287 EYE HAEMORRHAGE 13 0.0010
288 PERIPHERAL VASCULAR DISORDER 5 0.0010
289 VENTRICULAR TACHYCARDIA 16 0.0010
290 BENIGN PROSTATIC HYPERPLASIA 5 0.0010
291 VARICOSE VEIN 5 0.0010
292 STOMACH DISCOMFORT 5 0.0010
293 ATRIAL FIBRILLATION 94 0.0010
294 FAILURE TO THRIVE 5 0.0010
295 PRE-EXISTING CONDITION IMPROVED 6 0.0010
296 BLOOD UREA INCREASED 16 0.0010
297 NYSTAGMUS 5 0.0009
298 ASPARTATE AMINOTRANSFERASE INCREASED 50 0.0009
299 SYNCOPE 94 0.0009
300 FOOD POISONING 5 0.0009
301 PROCTALGIA 6 0.0009
302 CARPAL TUNNEL SYNDROME 13 0.0009
303 MUSCLE STRAIN 8 0.0009
304 URINE OUTPUT DECREASED 8 0.0009
305 HEPATIC STEATOSIS 17 0.0009
306 PHARYNGEAL OEDEMA 14 0.0009
307 LUNG INFILTRATION 8 0.0009
308 LOW DENSITY LIPOPROTEIN INCREASED 7 0.0009
309 CATHETERISATION CARDIAC 4 0.0009
310 DIVERTICULITIS 25 0.0009
311 DRUG INTERACTION 143 0.0009
312 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 47 0.0009
313 HEART RATE ABNORMAL 5 0.0009
314 HAEMOGLOBIN DECREASED 92 0.0009
315 GLOMERULAR FILTRATION RATE DECREASED 11 0.0009
316 RENAL IMPAIRMENT 75 0.0009
317 EMPHYSEMA 9 0.0009
318 TRANSIENT ISCHAEMIC ATTACK 30 0.0009
319 SINUS CONGESTION 12 0.0009
320 SKIN TOXICITY 5 0.0009
321 DRUG EFFECT DELAYED 4 0.0009
322 RENAL CYST 7 0.0009
323 DRUG TOXICITY 12 0.0009
324 BLOOD THYROID STIMULATING HORMONE DECREASED 4 0.0009
325 HAEMATURIA 30 0.0009
326 EAR DISORDER 4 0.0009
327 OEDEMA PERIPHERAL 106 0.0009
328 INCREASED TENDENCY TO BRUISE 8 0.0009
329 EXERCISE TOLERANCE DECREASED 5 0.0009
330 STENT PLACEMENT 7 0.0009
331 BRADYCARDIA 46 0.0009
332 BLOOD GLUCOSE ABNORMAL 16 0.0009
333 BLOOD CHOLESTEROL ABNORMAL 4 0.0009
334 MENTAL STATUS CHANGES 24 0.0009
335 GASTROOESOPHAGEAL REFLUX DISEASE 69 0.0009
336 FREQUENT BOWEL MOVEMENTS 23 0.0009
337 SKIN ULCER 22 0.0009
338 DIABETES MELLITUS INADEQUATE CONTROL 15 0.0008
339 DIVERTICULUM 6 0.0008
340 BODY HEIGHT DECREASED 9 0.0008
341 SINUS HEADACHE 5 0.0008
342 EOSINOPHIL COUNT INCREASED 7 0.0008
343 LUNG INFECTION 13 0.0008
344 DISORIENTATION 33 0.0008
345 HEPATITIS B 5 0.0008
346 SHOCK 19 0.0008
347 HAEMORRHOIDS 16 0.0008
348 VITAMIN D DECREASED 7 0.0008
349 DEPRESSED MOOD 43 0.0008
350 MENISCUS INJURY 5 0.0008
351 ABDOMINAL TENDERNESS 4 0.0008
352 MALNUTRITION 9 0.0008
353 MUSCULOSKELETAL PAIN 42 0.0008
354 CHEST DISCOMFORT 82 0.0008
355 GROIN PAIN 7 0.0008
356 RHINORRHOEA 51 0.0008
357 HAEMOPTYSIS 22 0.0008
358 AORTIC ANEURYSM 6 0.0008
359 METABOLIC ACIDOSIS 25 0.0008
360 COAGULOPATHY 13 0.0008
361 INFLUENZA 87 0.0008
362 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 8 0.0008
363 MOVEMENT DISORDER 25 0.0008
364 CEREBRAL ISCHAEMIA 4 0.0008
365 ATRIOVENTRICULAR BLOCK 6 0.0008
366 ANOREXIA 10 0.0008
367 LIMB DISCOMFORT 24 0.0008
368 INCOHERENT 5 0.0008
369 CHEST PAIN 143 0.0008
370 LACTIC ACIDOSIS 25 0.0008
371 PELVIC FRACTURE 6 0.0008
372 RECTAL HAEMORRHAGE 33 0.0008
373 PETECHIAE 8 0.0008
374 EXOSTOSIS 7 0.0008
375 POLYP 5 0.0008
376 BLOOD THYROID STIMULATING HORMONE INCREASED 7 0.0008
377 ATAXIA 9 0.0008
378 INCONTINENCE 8 0.0008
379 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
380 FEELING COLD 21 0.0008
381 COMPRESSION FRACTURE 4 0.0007
382 HYPONATRAEMIA 42 0.0007
383 LACERATION 7 0.0007
384 FEAR 20 0.0007
385 ULCER HAEMORRHAGE 5 0.0007
386 SHOCK HAEMORRHAGIC 6 0.0007
387 SKIN LACERATION 8 0.0007
388 DYSURIA 27 0.0007
389 OSTEOARTHRITIS 31 0.0007
390 BLOOD GLUCOSE FLUCTUATION 8 0.0007
391 ECCHYMOSIS 5 0.0007
392 DYSPNOEA 411 0.0007
393 WEIGHT DECREASED 202 0.0007
394 DIZZINESS POSTURAL 7 0.0007
395 TOOTH DISORDER 16 0.0007
396 PARKINSONISM 7 0.0007
397 HUNGER 10 0.0007
398 RESTLESS LEGS SYNDROME 13 0.0007
399 HAEMODIALYSIS 6 0.0007
400 COELIAC DISEASE 7 0.0007
401 NEPHROPATHY TOXIC 8 0.0007
402 KNEE ARTHROPLASTY 15 0.0007
403 OXYGEN SATURATION DECREASED 40 0.0007
404 BODY TEMPERATURE DECREASED 7 0.0007
405 HAND FRACTURE 5 0.0007
406 SINUS TACHYCARDIA 10 0.0007
407 BLOOD MAGNESIUM DECREASED 6 0.0007
408 MUSCULAR WEAKNESS 79 0.0007
409 BLOOD URIC ACID INCREASED 4 0.0007
410 FAECES DISCOLOURED 15 0.0007
411 SKIN SWELLING 6 0.0007
412 DERMATITIS BULLOUS 5 0.0007
413 MADAROSIS 8 0.0007
414 HYPERGLYCAEMIA 25 0.0007
415 PAIN IN EXTREMITY 202 0.0007
416 BLOOD URINE PRESENT 13 0.0007
417 PROTEINURIA 13 0.0007
418 DEHYDRATION 91 0.0007
419 AGEUSIA 17 0.0007
420 COUGH 191 0.0007
421 BLOOD TRIGLYCERIDES INCREASED 12 0.0007
422 BACK DISORDER 11 0.0007
423 ASTHENIA 254 0.0007
424 BLOOD IRON DECREASED 8 0.0007
425 CARDIAC FAILURE 54 0.0007
426 ISCHAEMIC STROKE 12 0.0007
427 POLLAKIURIA 28 0.0007
428 COLON CANCER 10 0.0007
429 SUNBURN 5 0.0007
430 FLATULENCE 38 0.0007
431 HAEMORRHAGE INTRACRANIAL 10 0.0007
432 FEELING HOT 41 0.0007
433 DIABETIC KETOACIDOSIS 16 0.0007
434 PHOTOSENSITIVITY REACTION 11 0.0007
435 HALLUCINATION, VISUAL 14 0.0007
436 BRONCHITIS 49 0.0007
437 LOCALISED INFECTION 16 0.0007
438 NOCTURIA 8 0.0007
439 UNRESPONSIVE TO STIMULI 17 0.0007
440 BONE DISORDER 12 0.0007
441 RETCHING 14 0.0007
442 ACTIVITIES OF DAILY LIVING IMPAIRED 13 0.0007
443 PERIPHERAL COLDNESS 9 0.0007
444 BLOOD PRESSURE ABNORMAL 13 0.0007
445 HIP FRACTURE 21 0.0007
446 BOWEL MOVEMENT IRREGULARITY 5 0.0007
447 LIPASE INCREASED 5 0.0007
448 FACE OEDEMA 11 0.0007
449 RESPIRATORY DISTRESS 18 0.0007
450 HYPERTENSION 138 0.0007
451 DYSSTASIA 19 0.0007
452 SMALL INTESTINAL OBSTRUCTION 8 0.0006
453 PERICARDIAL EFFUSION 15 0.0006
454 INJECTION SITE EXTRAVASATION 8 0.0006
455 PRURITUS GENERALISED 14 0.0006
456 PHARYNGITIS 8 0.0006
457 RESPIRATORY FAILURE 47 0.0006
458 NECK PAIN 36 0.0006
459 ABDOMINAL DISCOMFORT 108 0.0006
460 DEFORMITY 6 0.0006
461 HYPOGLYCAEMIA 31 0.0006
462 HEPATIC CIRRHOSIS 12 0.0006
463 GASTROINTESTINAL INFLAMMATION 5 0.0006
464 MULTIPLE ALLERGIES 5 0.0006
465 DELIRIUM 22 0.0006
466 PAIN 389 0.0006
467 SPUTUM DISCOLOURED 6 0.0006
468 DYSPEPSIA 62 0.0006
469 DIABETES MELLITUS 48 0.0006
470 OBESITY 10 0.0006
471 CARDIOGENIC SHOCK 9 0.0006
472 METASTASES TO LIVER 11 0.0006
473 GLOSSODYNIA 14 0.0006
474 ORAL PAIN 14 0.0006
475 MYOCARDIAL INFARCTION 109 0.0006
476 PANCREATIC CARCINOMA 18 0.0006
477 HYPERCHOLESTEROLAEMIA 6 0.0006
478 SINUS BRADYCARDIA 6 0.0006
479 PLATELET COUNT DECREASED 66 0.0006
480 FLUID OVERLOAD 9 0.0006
481 ABNORMAL DREAMS 17 0.0006
482 EPISTAXIS 46 0.0006
483 MICTURITION URGENCY 7 0.0006
484 VITREOUS FLOATERS 6 0.0006
485 ARTHRITIS 48 0.0006
486 HYPOAESTHESIA 91 0.0006
487 ORAL CANDIDIASIS 8 0.0006
488 DYSGRAPHIA 4 0.0006
489 COLITIS 23 0.0006
490 PANCREATITIS 32 0.0006
491 CONTUSION 58 0.0006
492 LIP SWELLING 20 0.0006
493 HEAD INJURY 19 0.0006
494 SPINAL FRACTURE 12 0.0006
495 BREAST MASS 4 0.0006
496 HEART RATE INCREASED 59 0.0006
497 SENSATION OF FOREIGN BODY 5 0.0006
498 OSTEOPENIA 9 0.0006
499 ASTHMA 67 0.0006
500 SEPSIS 66 0.0006
501 MELAENA 13 0.0006
502 HEMIPARESIS 10 0.0006
503 FLUID RETENTION 30 0.0006
504 TOOTH ABSCESS 6 0.0006
505 PALLOR 16 0.0006
506 BLOOD PRESSURE DECREASED 39 0.0006
507 BACK PAIN 136 0.0006
508 MUSCLE RIGIDITY 7 0.0006
509 INITIAL INSOMNIA 6 0.0006
510 CEREBROVASCULAR ACCIDENT 99 0.0006
511 PERIPHERAL SWELLING 90 0.0006
512 WRIST FRACTURE 7 0.0006
513 THYROID DISORDER 9 0.0006
514 HELICOBACTER INFECTION 6 0.0006
515 RIB FRACTURE 12 0.0006
516 BLOOD CREATININE INCREASED 38 0.0006
517 CARDIAC OPERATION 5 0.0006
518 TENDONITIS 9 0.0006
519 MUSCULOSKELETAL DISCOMFORT 10 0.0006
520 RASH PAPULAR 13 0.0006
521 DRY MOUTH 47 0.0006
522 HYPERBILIRUBINAEMIA 6 0.0006
523 DROOLING 4 0.0006
524 HAEMATOMA 15 0.0006
525 DYSGEUSIA 43 0.0006
526 GASTRIC ULCER 11 0.0006
527 SLEEP APNOEA SYNDROME 11 0.0006
528 NEURALGIA 14 0.0006
529 CONFUSIONAL STATE 93 0.0006
530 INTENTIONAL DRUG MISUSE 12 0.0006
531 URINARY INCONTINENCE 17 0.0006
532 VISUAL ACUITY REDUCED 19 0.0006
533 ACUTE RESPIRATORY FAILURE 11 0.0006
534 OEDEMA 31 0.0006
535 MUSCULOSKELETAL STIFFNESS 50 0.0006
536 INCORRECT DRUG ADMINISTRATION DURATION 16 0.0006
537 TUMOUR LYSIS SYNDROME 5 0.0006
538 PNEUMOTHORAX 9 0.0006
539 ABDOMINAL DISTENSION 59 0.0006
540 PURPURA 5 0.0006
541 NASOPHARYNGITIS 104 0.0006
542 ILEUS 7 0.0006
543 APHASIA 17 0.0006
544 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 27 0.0006
545 MUSCLE SPASMS 103 0.0006
546 FACIAL PAIN 5 0.0006
547 INSOMNIA 149 0.0006
548 PLEURAL EFFUSION 34 0.0006
549 PULMONARY OEDEMA 25 0.0006
550 JAUNDICE 15 0.0006
551 POOR QUALITY SLEEP 12 0.0006
552 URTICARIA 93 0.0006
553 SWELLING FACE 36 0.0006
554 EMOTIONAL DISORDER 17 0.0006
555 PULMONARY THROMBOSIS 6 0.0005
556 LIVER FUNCTION TEST ABNORMAL 16 0.0005
557 OESOPHAGITIS 6 0.0005
558 GAIT DISTURBANCE 105 0.0005
559 WOUND INFECTION 6 0.0005
560 DYSPHONIA 32 0.0005
561 FULL BLOOD COUNT DECREASED 11 0.0005
562 DIARRHOEA 352 0.0005
563 ERECTILE DYSFUNCTION 14 0.0005
564 MYALGIA 92 0.0005
565 VENTRICULAR FIBRILLATION 6 0.0005
566 ARTHROPOD BITE 4 0.0005
567 JOINT SWELLING 65 0.0005
568 PULMONARY MASS 8 0.0005
569 CELLULITIS 27 0.0005
570 PRESYNCOPE 13 0.0005
571 SPEECH DISORDER 28 0.0005
572 CANDIDA INFECTION 9 0.0005
573 ANHEDONIA 14 0.0005
574 DYSARTHRIA 20 0.0005
575 SARS-COV-2 TEST POSITIVE 7 0.0005
576 DIZZINESS 264 0.0005
577 CIRCULATORY COLLAPSE 9 0.0005
578 BURNING SENSATION 37 0.0005
579 SCAB 6 0.0005
580 FEELING JITTERY 10 0.0005
581 GASTRIC DISORDER 18 0.0005
582 PRODUCT QUALITY ISSUE 71 0.0005
583 SKIN DISCOLOURATION 24 0.0005
584 FEELING ABNORMAL 125 0.0005
585 HYPERHIDROSIS 67 0.0005
586 GLAUCOMA 10 0.0005
587 CHOLELITHIASIS 17 0.0005
588 LYMPHOMA 8 0.0005
589 MUSCULOSKELETAL CHEST PAIN 8 0.0005
590 ANKLE FRACTURE 8 0.0005
591 NERVOUSNESS 27 0.0005
592 NAUSEA 408 0.0005
593 UNEVALUABLE EVENT 39 0.0005
594 POST PROCEDURAL HAEMORRHAGE 6 0.0005
595 RENAL DISORDER 24 0.0005
596 DELUSION 8 0.0005
597 IMPAIRED WORK ABILITY 11 0.0005
598 HAEMATEMESIS 13 0.0005
599 HYPOXIA 18 0.0005
600 HYPOACUSIS 22 0.0005
601 DEEP VEIN THROMBOSIS 33 0.0005
602 HOSPICE CARE 5 0.0005
603 BACTERAEMIA 6 0.0005
604 SINUS DISORDER 10 0.0005
605 MACULAR DEGENERATION 6 0.0005
606 SWELLING 47 0.0005
607 COORDINATION ABNORMAL 7 0.0005
608 DRUG EFFECT DECREASED 27 0.0005
609 MALAISE 218 0.0005
610 CARDIAC ARREST 41 0.0005
611 NIGHT SWEATS 16 0.0005
612 BLINDNESS UNILATERAL 7 0.0005
613 PRODUCT PHYSICAL ISSUE 10 0.0005
614 DRUG EFFECT INCOMPLETE 18 0.0005
615 WRONG TECHNIQUE IN DRUG USAGE PROCESS 18 0.0005
616 CRYING 18 0.0005
617 FIBROMYALGIA 12 0.0005
618 NO THERAPEUTIC RESPONSE 6 0.0005
619 DECUBITUS ULCER 4 0.0005
620 SUBDURAL HAEMATOMA 7 0.0005
621 NEUTROPHIL COUNT INCREASED 5 0.0005
622 ABNORMAL FAECES 4 0.0005
623 PNEUMONIA 158 0.0005
624 THERAPY CESSATION 25 0.0005
625 OSTEOPOROSIS 20 0.0005
626 HYPERCALCAEMIA 6 0.0005
627 CYST 6 0.0005
628 ACUTE CORONARY SYNDROME 4 0.0005
629 INFUSION RELATED REACTION 32 0.0005
630 HYPOKINESIA 7 0.0005
631 PULMONARY HYPERTENSION 10 0.0005
632 TENDERNESS 5 0.0005
633 DEPRESSION 109 0.0005
634 WEIGHT FLUCTUATION 5 0.0005
635 SOMNOLENCE 96 0.0005
636 HYPOKALAEMIA 22 0.0005
637 OROPHARYNGEAL PAIN 44 0.0005
638 TREATMENT NONCOMPLIANCE 26 0.0005
639 FOOT FRACTURE 9 0.0005
640 DRUG ADMINISTERED AT INAPPROPRIATE SITE 5 0.0005
641 RESPIRATORY ARREST 13 0.0005
642 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
643 INCREASED APPETITE 9 0.0005
644 PULMONARY FIBROSIS 9 0.0005
645 THERAPEUTIC RESPONSE UNEXPECTED 21 0.0005
646 BLINDNESS 19 0.0005
647 HEREDITARY ANGIOEDEMA 5 0.0005
648 DRUG INTOLERANCE 45 0.0005
649 PRESCRIBED OVERDOSE 9 0.0005
650 SKIN CANCER 10 0.0005
651 HYPOAESTHESIA ORAL 7 0.0005
652 RASH GENERALISED 12 0.0005
653 HIATUS HERNIA 6 0.0005
654 EAR PAIN 9 0.0005
655 VOMITING 217 0.0005
656 PALPITATIONS 54 0.0005
657 INJECTION SITE MASS 17 0.0005
658 SINUSITIS 47 0.0005
659 DRUG DISPENSING ERROR 7 0.0005
660 DRUG ABUSE 38 0.0005
661 ANAEMIA 87 0.0005
662 GASTRITIS 12 0.0005
663 CARDIO-RESPIRATORY ARREST 19 0.0005
664 LOSS OF CONSCIOUSNESS 58 0.0005
665 FEMUR FRACTURE 14 0.0005
666 DENTAL CARIES 5 0.0005
667 PRESCRIBED UNDERDOSE 9 0.0005
668 FOOT DEFORMITY 5 0.0005
669 INTESTINAL OBSTRUCTION 17 0.0005
670 NERVE INJURY 5 0.0004
671 BASAL CELL CARCINOMA 7 0.0004
672 THIRST 8 0.0004
673 QUALITY OF LIFE DECREASED 6 0.0004
674 SNEEZING 10 0.0004
675 FATIGUE 347 0.0004
676 ABASIA 11 0.0004
677 PRURITUS 171 0.0004
678 ANAL INCONTINENCE 4 0.0004
679 ALOPECIA 87 0.0004
680 RASH PRURITIC 24 0.0004
681 EYE INFECTION 5 0.0004
682 TACHYPNOEA 6 0.0004
683 LABORATORY TEST ABNORMAL 13 0.0004
684 RHEUMATOID ARTHRITIS 50 0.0004
685 PNEUMONIA ASPIRATION 11 0.0004
686 IMPAIRED GASTRIC EMPTYING 6 0.0004
687 HEPATIC ENZYME INCREASED 30 0.0004
688 IMPAIRED DRIVING ABILITY 5 0.0004
689 GINGIVAL BLEEDING 6 0.0004
690 RASH ERYTHEMATOUS 21 0.0004
691 CARDIAC DISORDER 41 0.0004
692 ARTHRALGIA 182 0.0004
693 PLASMA CELL MYELOMA 17 0.0004
694 DRUG DOSE OMISSION 72 0.0004
695 ABDOMINAL PAIN LOWER 11 0.0004
696 HAEMATOCHEZIA 24 0.0004
697 DECREASED APPETITE 101 0.0004
698 INTENTIONAL PRODUCT MISUSE 38 0.0004
699 TREMOR 72 0.0004
700 AMNESIA 28 0.0004
701 VISION BLURRED 59 0.0004
702 BLOOD CHOLESTEROL INCREASED 20 0.0004
703 ANXIETY 122 0.0004
704 MIDDLE INSOMNIA 8 0.0004
705 BLOOD TEST ABNORMAL 6 0.0004
706 SLEEP DISORDER 30 0.0004
707 HOT FLUSH 32 0.0004
708 LYMPHADENOPATHY 15 0.0004
709 DIALYSIS 6 0.0004
710 INTENTIONAL PRODUCT USE ISSUE 37 0.0004
711 NEUROPATHY PERIPHERAL 40 0.0004
712 MUSCULOSKELETAL DISORDER 8 0.0004
713 CONVULSION 24 0.0004
714 DYSKINESIA 17 0.0004
715 IMPAIRED QUALITY OF LIFE 6 0.0004
716 LETHARGY 24 0.0004
717 WHITE BLOOD CELL COUNT INCREASED 16 0.0004
718 CHOLESTASIS 8 0.0004
719 PYREXIA 144 0.0004
720 ANOSMIA 6 0.0004
721 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
722 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
723 ILL-DEFINED DISORDER 25 0.0004
724 ORAL HERPES 8 0.0004
725 SKIN FISSURES 8 0.0004
726 ABDOMINAL PAIN UPPER 84 0.0004
727 BLOOD BILIRUBIN INCREASED 11 0.0004
728 PARANOIA 7 0.0004
729 MULTI-ORGAN FAILURE 7 0.0004
730 SKIN HAEMORRHAGE 6 0.0004
731 DISABILITY 8 0.0004
732 TOOTH EXTRACTION 5 0.0004
733 PANCREATITIS ACUTE 9 0.0004
734 PSORIASIS 52 0.0004
735 WEIGHT INCREASED 89 0.0004
736 IMPAIRED HEALING 13 0.0004
737 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 28 0.0004
738 DISCOMFORT 24 0.0004
739 DRUG LEVEL DECREASED 4 0.0004
740 HIP ARTHROPLASTY 6 0.0004
741 MYDRIASIS 5 0.0004
742 EAR DISCOMFORT 4 0.0004
743 URINARY RETENTION 13 0.0004
744 ERYTHEMA 80 0.0004
745 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 10 0.0004
746 SYNOVITIS 7 0.0004
747 INJECTION SITE HAEMORRHAGE 31 0.0004
748 TOOTH LOSS 8 0.0004
749 THROMBOSIS 31 0.0004
750 NODULE 5 0.0004
751 EYE IRRITATION 22 0.0004
752 URINARY TRACT INFECTION 65 0.0004
753 INCORRECT PRODUCT STORAGE 5 0.0004
754 COLITIS ULCERATIVE 17 0.0004
755 TOOTH INFECTION 5 0.0004
756 RESPIRATORY TRACT CONGESTION 6 0.0004
757 ADVERSE REACTION 5 0.0004
758 CHILLS 44 0.0004
759 PARAESTHESIA 59 0.0004
760 JOINT INJURY 8 0.0004
761 BLISTER 21 0.0004
762 TACHYCARDIA 33 0.0004
763 UNDERDOSE 27 0.0004
764 PSORIATIC ARTHROPATHY 15 0.0004
765 PRODUCT TASTE ABNORMAL 5 0.0004
766 BACK INJURY 4 0.0004
767 SEPTIC SHOCK 16 0.0004
768 AGITATION 27 0.0004
769 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
770 ENCEPHALOPATHY 9 0.0004
771 LOWER LIMB FRACTURE 7 0.0004
772 LACRIMATION INCREASED 11 0.0004
773 DRY EYE 18 0.0004
774 PRODUCT USE IN UNAPPROVED INDICATION 89 0.0004
775 ROAD TRAFFIC ACCIDENT 15 0.0004
776 HALLUCINATION 27 0.0004
777 MEMORY IMPAIRMENT 49 0.0004
778 THROAT IRRITATION 16 0.0004
779 ANGER 12 0.0004
780 DRUG INEFFECTIVE 465 0.0004
781 APPLICATION SITE PRURITUS 8 0.0004
782 ABDOMINAL PAIN 82 0.0004
783 PRODUCT DOSE OMISSION 23 0.0004
784 HYPOPHAGIA 9 0.0004
785 CONDITION AGGRAVATED 107 0.0004
786 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 25 0.0004
787 DERMATITIS CONTACT 4 0.0004
788 SCAR 6 0.0004
789 CHOLECYSTECTOMY 4 0.0003
790 HYPERSOMNIA 10 0.0003
791 NEPHROLITHIASIS 16 0.0003
792 DYSPHAGIA 33 0.0003
793 MUSCLE TWITCHING 8 0.0003
794 PARAESTHESIA ORAL 5 0.0003
795 CYSTITIS 11 0.0003
796 HYPERTHYROIDISM 5 0.0003
797 INJECTION SITE HAEMATOMA 5 0.0003
798 HYPOTHYROIDISM 11 0.0003
799 HAEMORRHAGE 36 0.0003
800 JOINT STIFFNESS 9 0.0003
801 HEADACHE 215 0.0003
802 APATHY 5 0.0003
803 ASCITES 10 0.0003
804 LYMPHOCYTE COUNT DECREASED 6 0.0003
805 EAR INFECTION 9 0.0003
806 DISEASE PROGRESSION 40 0.0003
807 PULMONARY EMBOLISM 32 0.0003
808 CHOLECYSTITIS 4 0.0003
809 IMMUNODEFICIENCY 5 0.0003
810 ACCIDENT 4 0.0003
811 RESPIRATORY DISORDER 10 0.0003
812 DISTURBANCE IN ATTENTION 18 0.0003
813 THROAT TIGHTNESS 9 0.0003
814 RASH 145 0.0003
815 GASTROENTERITIS VIRAL 6 0.0003
816 SKIN DISORDER 11 0.0003
817 BURSITIS 4 0.0003
818 SKIN LESION 9 0.0003
819 LIVER FUNCTION TEST INCREASED 7 0.0003
820 AGRANULOCYTOSIS 6 0.0003
821 EYE SWELLING 12 0.0003
822 DEVICE DISLOCATION 14 0.0003
823 BACTERIAL INFECTION 6 0.0003
824 PAIN IN JAW 9 0.0003
825 FRACTURE 6 0.0003
826 BRAIN OEDEMA 4 0.0003
827 NEOPLASM PROGRESSION 11 0.0003
828 VISUAL IMPAIRMENT 39 0.0003
829 HALLUCINATION, AUDITORY 5 0.0003
830 RASH MACULO-PAPULAR 7 0.0003
831 DEVICE MALFUNCTION 22 0.0003
832 POST PROCEDURAL COMPLICATION 6 0.0003
833 HYPERSENSITIVITY 58 0.0003
834 DRUG PRESCRIBING ERROR 6 0.0003
835 ERUCTATION 6 0.0003
836 NEEDLE ISSUE 9 0.0003
837 DIPLOPIA 8 0.0003
838 PRODUCT ADHESION ISSUE 11 0.0003
839 OVERDOSE 66 0.0003
840 ELECTROCARDIOGRAM QT PROLONGED 11 0.0003
841 TINNITUS 14 0.0003
842 WHITE BLOOD CELL COUNT DECREASED 33 0.0003
843 MULTIPLE FRACTURES 5 0.0003
844 BEDRIDDEN 4 0.0003
845 EYE DISORDER 10 0.0003
846 ABNORMAL BEHAVIOUR 12 0.0003
847 UPPER LIMB FRACTURE 6 0.0003
848 RESTLESSNESS 11 0.0003
849 VIRAL INFECTION 10 0.0003
850 GAIT INABILITY 10 0.0003
851 MENTAL DISORDER 13 0.0003
852 SKIN EXFOLIATION 25 0.0003
853 HERPES ZOSTER 17 0.0003
854 VERTIGO 18 0.0003
855 BODY TEMPERATURE INCREASED 6 0.0003
856 PNEUMONITIS 8 0.0003
857 ACUTE HEPATIC FAILURE 4 0.0003
858 DRY SKIN 39 0.0003
859 LUNG NEOPLASM MALIGNANT 12 0.0003
860 INFLAMMATION 15 0.0003
861 NIGHTMARE 10 0.0003
862 ARTHROPATHY 16 0.0003
863 LUNG DISORDER 14 0.0003
864 COLD SWEAT 5 0.0003
865 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 51 0.0003
866 EATING DISORDER 6 0.0003
867 GALLBLADDER DISORDER 5 0.0003
868 IRRITABLE BOWEL SYNDROME 6 0.0003
869 CEREBRAL HAEMORRHAGE 10 0.0003
870 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
871 TOOTHACHE 5 0.0003
872 INCORRECT DOSE ADMINISTERED 63 0.0003
873 PELVIC PAIN 5 0.0003
874 DRUG RESISTANCE 7 0.0003
875 APPLICATION SITE PAIN 6 0.0003
876 ANAPHYLACTIC REACTION 15 0.0003
877 FUNGAL INFECTION 9 0.0003
878 STEVENS-JOHNSON SYNDROME 6 0.0003
879 CONJUNCTIVITIS 5 0.0003
880 PRODUCT USE ISSUE 50 0.0003
881 PHOTOPHOBIA 5 0.0003
882 HYPOCALCAEMIA 5 0.0003
883 STOMATITIS 16 0.0003
884 DEVICE FAILURE 4 0.0003
885 INJECTION SITE PAIN 80 0.0003
886 DRUG ADMINISTRATION ERROR 8 0.0003
887 LIMB INJURY 7 0.0003
888 MOOD ALTERED 7 0.0003
889 CHOKING 5 0.0003
890 SYSTEMIC LUPUS ERYTHEMATOSUS 9 0.0003
891 OCULAR HYPERAEMIA 12 0.0003
892 MEDICATION ERROR 14 0.0003
893 MIGRAINE 24 0.0003
894 SKIN BURNING SENSATION 18 0.0003
895 SUICIDAL IDEATION 23 0.0003
896 WOUND 7 0.0003
897 OFF LABEL USE 216 0.0002
898 FEEDING DISORDER 5 0.0002
899 TASTE DISORDER 5 0.0002
900 MALIGNANT NEOPLASM PROGRESSION 25 0.0002
901 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
902 EMOTIONAL DISTRESS 29 0.0002
903 ADVERSE EVENT 22 0.0002
904 INJECTION SITE BRUISING 19 0.0002
905 PSYCHOTIC DISORDER 7 0.0002
906 GASTRIC CANCER 6 0.0002
907 ADVERSE DRUG REACTION 21 0.0002
908 DISEASE RECURRENCE 11 0.0002
909 INFLUENZA LIKE ILLNESS 19 0.0002
910 APPLICATION SITE ERYTHEMA 6 0.0002
911 EOSINOPHILIA 4 0.0002
912 INJECTION SITE RASH 7 0.0002
913 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
914 HEPATOTOXICITY 5 0.0002
915 GASTROINTESTINAL DISORDER 20 0.0002
916 DRUG-INDUCED LIVER INJURY 7 0.0002
917 DEVICE ISSUE 20 0.0002
918 PAIN OF SKIN 6 0.0002
919 INFECTION 32 0.0002
920 NEUTROPHIL COUNT DECREASED 9 0.0002
921 DEATH 190 0.0002
922 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
923 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
924 ILLNESS 22 0.0002
925 EYE PAIN 12 0.0002
926 TARDIVE DYSKINESIA 6 0.0002
927 STAPHYLOCOCCAL INFECTION 7 0.0002
928 COMA 10 0.0002
929 PRODUCT PRESCRIBING ERROR 5 0.0002
930 NEOPLASM MALIGNANT 14 0.0002
931 EYE PRURITUS 7 0.0002
932 MENTAL IMPAIRMENT 5 0.0002
933 DYSTONIA 4 0.0002
934 THROMBOCYTOPENIA 23 0.0002
935 SURGERY 12 0.0002
936 CEREBRAL INFARCTION 5 0.0002
937 AGGRESSION 10 0.0002
938 IRRITABILITY 12 0.0002
939 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
940 THERAPEUTIC RESPONSE DECREASED 12 0.0002
941 PANCYTOPENIA 11 0.0002
942 HEPATITIS 5 0.0002
943 COVID-19 34 0.0002
944 BONE PAIN 11 0.0002
945 INTENTIONAL OVERDOSE 12 0.0002
946 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 36 0.0002
947 MULTIPLE SCLEROSIS RELAPSE 12 0.0002
948 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
949 COMPLETED SUICIDE 14 0.0002
950 MULTIPLE SCLEROSIS 8 0.0002
951 INTERSTITIAL LUNG DISEASE 8 0.0002
952 C-REACTIVE PROTEIN INCREASED 6 0.0002
953 SEIZURE 19 0.0002
954 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
955 VAGINAL HAEMORRHAGE 7 0.0002
956 BREAST CANCER 15 0.0002
957 NERVOUS SYSTEM DISORDER 5 0.0002
958 BONE DENSITY DECREASED 5 0.0002
959 LIVER DISORDER 7 0.0002
960 MOOD SWINGS 5 0.0002
961 INJECTION SITE ERYTHEMA 19 0.0002
962 FEBRILE NEUTROPENIA 10 0.0002
963 INJECTION SITE PRURITUS 10 0.0001
964 SUICIDE ATTEMPT 9 0.0001
965 EXTRA DOSE ADMINISTERED 6 0.0001
966 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
967 INJECTION SITE SWELLING 11 0.0001
968 HOSPITALISATION 22 0.0001
969 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
970 ECZEMA 7 0.0001
971 THERAPY NON-RESPONDER 6 0.0001
972 GENERAL PHYSICAL HEALTH DETERIORATION 15 0.0001
973 PRODUCT DOSE OMISSION ISSUE 36 0.0001
974 WITHDRAWAL SYNDROME 5 0.0001
975 DEVICE LEAKAGE 5 0.0001
976 DERMATITIS ATOPIC 6 0.0001
977 ACCIDENTAL OVERDOSE 4 0.0001
978 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5 0.0001
979 RENAL CANCER 5 0.0001
980 DRUG WITHDRAWAL SYNDROME 9 0.0001
981 LEUKOPENIA 5 0.0001
982 PROSTATE CANCER 8 0.0001
983 BLADDER CANCER 5 0.0001
984 THERAPY INTERRUPTED 6 0.0001
985 NEUTROPENIA 10 0.0001
986 INJECTION SITE REACTION 5 0.0001
987 TREATMENT FAILURE 6 0.0001
988 PRODUCT STORAGE ERROR 6 0.0001
989 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
990 ACNE 5 0.0001
991 DRUG DEPENDENCE 8 0.0000